HQH · abrdn Healthcare Investors · Fund Holdings
Market Cap
$1.35B
Shares
57.19M
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
abrdn Healthcare Investors
Reported 2026-06-30Net Assets
$1,361,998,924
Total Assets
$1,364,376,428
Holdings
167
Filed
2026-08-28
| Holding | CUSIP | Balance | Units | Value | % Net Assets | Category | Country |
|---|---|---|---|---|---|---|---|
| uniQure NV | 000000000 | 1,240,256 | NS | $57,126,191 | 4.19% | EC | NL |
| VeraDermics Inc | 922967104 | 378,002 | NS | $46,471,566 | 3.41% | EC | US |
| Insmed Inc | 457669307 | 357,466 | NS | $38,113,025 | 2.80% | EC | US |
| Argenx SE | 04016X101 | 36,476 | NS | $33,841,339 | 2.48% | EC | NL |
| VERADERMICS, INC. | 000000000 | 249,839 | NS | $30,715,207 | 2.26% | EP | US |
| Personalis Inc | 71535D106 | 2,204,516 | NS | $29,540,514 | 2.17% | EC | US |
| Tectonic Therapeutic Inc | 878972108 | 770,940 | NS | $26,501,063 | 1.95% | EC | US |
| Oruka Therapeutics Inc | 687604108 | 273,474 | NS | $26,026,521 | 1.91% | EC | US |
| Abbott Laboratories | 002824100 | 273,941 | NS | $24,857,406 | 1.83% | EC | US |
| BioCryst Pharmaceuticals Inc | 09058V103 | 2,323,964 | NS | $23,239,640 | 1.71% | EC | US |
| UnitedHealth Group Inc | 91324P102 | 53,414 | NS | $22,200,461 | 1.63% | EC | US |
| Humana Inc | 444859102 | 55,623 | NS | $22,094,568 | 1.62% | EC | US |
| Denali Therapeutics Inc | 24823R105 | 857,414 | NS | $22,052,688 | 1.62% | EC | US |
| Amgen Inc | 031162100 | 55,824 | NS | $20,214,987 | 1.48% | EC | US |
| Immunovant Inc | 45258J102 | 519,819 | NS | $20,028,626 | 1.47% | EC | US |
| Abivax SA | 00370M103 | 150,132 | NS | $20,006,590 | 1.47% | EC | FR |
| Praxis Precision Medicines Inc | 74006W207 | 59,398 | NS | $19,885,856 | 1.46% | EC | US |
| Crinetics Pharmaceuticals Inc | 22663K107 | 508,242 | NS | $19,018,416 | 1.40% | EC | US |
| EyePoint Inc | 30233G209 | 1,220,913 | NS | $17,459,056 | 1.28% | EC | US |
| Medtronic PLC | 000000000 | 211,663 | NS | $16,558,396 | 1.22% | EC | IE |
| Danaher Corp | 235851102 | 86,804 | NS | $16,534,426 | 1.21% | EC | US |
| Intuitive Surgical Inc | 46120E602 | 41,349 | NS | $16,443,670 | 1.21% | EC | US |
| Dyne Therapeutics Inc | 26818M108 | 739,587 | NS | $16,426,227 | 1.21% | EC | US |
| NEUROVANCE MILESTONE INTEREST | 000000000 | 49,006 | NS | $16,424,401 | 1.21% | EC | US |
| Structure Therapeutics Inc | 86366E106 | 301,239 | NS | $16,167,497 | 1.19% | EC | KY |
| Newamsterdam Pharma Co NV | 000000000 | 476,416 | NS | $16,145,738 | 1.19% | EC | NL |
| CVS Health Corp | 126650100 | 154,920 | NS | $16,026,474 | 1.18% | EC | US |
| Edgewise Therapeutics Inc | 28036F105 | 383,924 | NS | $15,598,832 | 1.15% | EC | US |
| Revolution Medicines Inc | 76155X100 | 83,270 | NS | $15,594,806 | 1.14% | EC | US |
| Summit Therapeutics Inc | 86627T108 | 1,062,820 | NS | $15,485,287 | 1.14% | EC | US |
| Sarepta Therapeutics Inc | 803607100 | 844,819 | NS | $15,181,397 | 1.11% | EC | US |
| Thermo Fisher Scientific Inc | 883556102 | 28,689 | NS | $14,383,517 | 1.06% | EC | US |
| Xenon Pharmaceuticals Inc | 98420N105 | 237,877 | NS | $14,358,256 | 1.05% | EC | CA |
| Insulet Corp | 45784P101 | 92,541 | NS | $14,089,367 | 1.03% | EC | US |
| Boston Scientific Corp | 101137107 | 324,146 | NS | $13,834,551 | 1.02% | EC | US |
| IMMUNIC | 000000000 | 884,746 | NS | $13,598,551 | 1.00% | DE | US |
| Elevance Health Inc | 036752103 | 35,082 | NS | $13,567,262 | 1.00% | EC | US |
| Ionis Pharmaceuticals Inc | 462222100 | 170,945 | NS | $13,554,229 | 1.00% | EC | US |
| Charles River Laboratories International Inc | 159864107 | 58,698 | NS | $13,312,119 | 0.98% | EC | US |
| State Street Global Advisors | 857492706 | 12,638,668 | NS | $12,638,668 | 0.93% | STIV | US |
| Ideaya Biosciences Inc | 45166A102 | 338,878 | NS | $12,629,983 | 0.93% | EC | US |
| ARS Pharmaceuticals Inc | 82835W108 | 1,574,583 | NS | $12,612,410 | 0.93% | EC | US |
| NeoGenomics Inc | 64049M209 | 861,891 | NS | $12,574,990 | 0.92% | EC | US |
| Vericel Corp | 92346J108 | 280,492 | NS | $12,479,089 | 0.92% | EC | US |
| Adaptive Biotechnologies Corp | 00650F109 | 574,345 | NS | $12,319,700 | 0.90% | EC | US |
| Palvella Therapeutics Inc | 697947109 | 79,433 | NS | $12,138,951 | 0.89% | EC | US |
| Arrowhead Pharmaceuticals Inc | 04280A100 | 147,490 | NS | $12,021,910 | 0.88% | EC | US |
| Vaxcyte Inc | 92243G108 | 206,804 | NS | $12,021,517 | 0.88% | EC | US |
| GeneDx Holdings Corp | 81663L200 | 163,598 | NS | $11,231,003 | 0.82% | EC | US |
| Jazz Pharmaceuticals PLC | 000000000 | 46,565 | NS | $11,220,768 | 0.82% | EC | IE |
Showing 1–50 of 167 holdings